Can talking to a Psycho-Oncologist make cancer doctors better at their jobs?
NCT ID NCT07268378
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether four one-hour supervision sessions with a psycho-oncologist can help oncology and hematology clinicians handle difficult patient interactions. The 62 participants are doctors or nurses who will discuss challenging cases and reflect on their feelings. The goal is to see if this support improves their ability to think about their work and reduces negative feelings toward patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- supervision sessions by psycho-oncologists
- What this could lead to
- If it works, this could point toward a practical way to support oncology clinicians, improving their well-being and relationships with patients.
- What could go wrong
- This is a small, early-stage study with only 62 participants, so results may not apply widely. It focuses on clinician outcomes, not direct patient benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Psychiatrie de liaison
Lausanne, Canton of Vaud, 1011, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates